Lindsey Misita
Payments from drug & device makers
Across 207 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$643
- Lilly USA, LLC$490
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$185
- Johnson & Johnson$120
- Amgen$110
- plus $693 from 16 others
What the payments were for
- Food & beverage$3,254100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $1,013 |
| Novo Nordisk | 43 | $643 |
| Lilly USA, LLC | 34 | $490 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $185 |
| Johnson & Johnson | 8 | $120 |
| Amgen | 7 | $110 |
| GSK | 6 | $99 |
| Boston Scientific | 1 | $93 |
| Esperion Therapeutics, Inc. | 5 | $74 |
| Exact Sciences | 4 | $73 |
| Bayer | 3 | $55 |
| Lundbeck LLC | 3 | $49 |
| AstraZeneca | 3 | $48 |
| Organon | 2 | $33 |
| Tris Pharma Inc | 2 | $31 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Dexcom, Inc. | 1 | $24 |
| Renalytix AI, Inc. | 1 | $23 |
| Pfizer | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Global Blood Therapeutics, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$3,254 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 83 | $118,016 |
| OzempicSemaglutide | 45 | $49,619 |
| TradjentaLinagliptin | 46 | $34,330 |
| JardianceEmpagliflozin | 36 | $33,727 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $27,224 |
| FarxigaDapagliflozin Propanediol | 19 | $23,052 |
| VascepaIcosapent Ethyl | 23 | $14,369 |
| EliquisApixaban | 19 | $13,111 |
| XareltoRivaroxaban | 15 | $9,208 |
| NexlizetBempedoic Acid/Ezetimibe | 11 | $6,743 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 79 | $1,995 |
| Diclofenac Sodium | 29 | $1,300 |
| Fluticasone Propionate | 42 | $912 |
| Gabapentin | 76 | $840 |
| Buspirone Hcl | 47 | $472 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $490 | $118,01683 claims |
| Boehringer IngelheimTradjenta, Jardiance | $14 | $68,05782 claims |
| Novo NordiskOzempic | $643 | $49,61945 claims |
| GSKTrelegy Ellipta | $99 | $27,22431 claims |
| AstraZenecaFarxiga | $48 | $23,05219 claims |
| PfizerEliquis | $18 | $13,11119 claims |
| Johnson & JohnsonXarelto | $120 | $9,20815 claims |
| Esperion Therapeutics, Inc.Nexlizet | $74 | $6,74311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,610 family providers in Louisiana.
Other family in Amite
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.